Not Yet RecruitingNot Applicable

Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation

100 participantsStarted 2025-07-01

Plain-language summary

The purpose of this study is to dynamically observe the dynamic changes of serum IGF-1 after intracerebral hemorrhage, explore the impact and correlation of serum IGF-1 with the severity of the patient's condition and prognosis, and provide a reference for clinical treatment timing.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged 18 to 75 years old;
✓. Patients with intracerebral hemorrhage (NIHSS ≥5 points);
✓. No history of cerebrovascular diseases with residual functional impairment before brain injury;
✓. Hospitalized within 72 hours after injury;
✓. BMI ≤28.

Exclusion criteria

✕. Patients with severe cardiac, hepatic, renal, or pulmonary dysfunction;
✕. Glycated hemoglobin \>9.0% at screening;
✕. History of hypothalamic-pituitary related diseases or severe endocrine diseases;
✕. Use of drugs affecting endocrine function (such as glucocorticoids, growth hormones) within the past six months;
✕. Pregnant patients. -

What they're measuring

The relationship between serum IGF-1 levels within 3 days after intracerebral hemorrhage and the severity of the condition (referring to NIHSS score)

Timeframe: 3 days after intracerebral

Trial details

NCT IDNCT07043504

SponsorShengjing Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

Contact for this trial

YanMei Yin, Master

18940259354 yym15998315189@163.com

View on ClinicalTrials.gov More Insulin-Like Growth Factor I trials